Surgical and orthopedic equipment maker
The pandemic hasn’t treated Avalign well. First, it crushed demand for surgery equipment as elective procedures were canceled. Now that demand is returning, the supply chain is causing problems.
S&P Global Ratings
Avalign has won several contracts recently and should be helped by a gradual rebound in orders, according to the report. But ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.